EMERGENCIES IN CORONAVIRUS DISEASE CAUSED BY COVID-19 VIRUS
In 2019, the new coronavirus was identified as the cause of a disease originating from the city of Wuhan in China, now known as SARS-CoV-2. The World Health Organization declared COVID-19 a pandemic in March 2020. Some people may have only a few symptoms or may not have any symptoms at all. Some people may experience worsening symptoms, such as shortness of breath and pneumonia, about a week after the onset of symptoms, and some may experience systemic complications caused by COVID-19 infection. Many of these complications can be caused by a condition known as cytokine release syndrome or cytokine storm. Cytokines can significantly damage vital organ tissue, including the lungs, heart, and kidneys. The pathology of coronavirus disease (COVID-19) is exacerbated by the progression of thrombosis, disseminated intravascular coagulation (DIC), and cytokine storm. Signs and symptoms of an emergency may include: difficulty breathing, rapid, shallow breathing, persistent chest pain or pressure, somnolence, confusion, collapse, pale, gray or blue skin, lips or nails - depending on skin tone. In hospitalized patients, constant monitoring and monitoring of parameters that may indicate a certain complication in the disease requiring prompt timely treatment, is necessary. The following emergency conditions, complications in COVID-19 have been described in this paper: acute respiratory failure, ARDS, COVID-19 coagulopathy and DIC, septic shock, rhabdomyolysis, acute renal failure, acute hepatic failure, acute heart disease, myocarditis, MIS-C, emergency neurological diseases and spontaneous rectus sheath hematoma.
Keywords: emergencies in COVID-19, cytokine storm, COVID-19 coagulopathy, COVID-19 complications, multisystem inflammatory syndrome in children, MIS-C.
2. Wang D, Hu B, Hu C, Zhu F, Liu X et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17; 323(11): 1061–1069. Published online 2020 Feb 7. doi: 10.1001/jama.2020.1585
3. Web MD, Complications Coronavirus can cause. www.webmd.com/lung/coronavirus-complications#1-2
4. Xu Li, Xiaochun Ma. Acute respiratory failure in COVID-19: is it "typical" ARDS? Crit Care. 2020 May 6; 24 (1):198. doi: 10.1186/s13054-020-02911-9.
5. Johns Hopkins medicine. COVID-19 Lung Damage. https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/what-coronavirus-does-to-the-lungs.
6. Peter G Gibson, Ling Qin, Ser Hon Puah. COVID‐19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre‐COVID‐19 ARDS. Med J Aust. 2020 Jul;213(2):54-56.e1. doi: 10.5694/mja2.50674. Epub 2020 Jun 22.
7. Marcel Levi and Toshiaki Iba. COVID-19 coagulopathy: is it disseminated intravascular coagulation? Intern Emerg Med. 2021; 16(2): 309–312. Published online 2020 Dec 24. doi: 10.1007/s11739-020-02601-y.
8. Alexander D. Makatsariya1 , Кristina N. Grigorieva1 , Marat A. Mingalimov1 , Viktoria O. et al. . Coronavirus disease (COVID-19) and disseminated intravascular coagulation. Sechenov university. Vol 14, No 2 (2020) https://doi.org/10.17749/2313-7347.132
9. Hidesaku Asakura and Haruhiko Ogawa. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2020 Nov 7 : 1–13.doi: 10.1007/s12185-020-03029-y.
10. Beltrán-García J, Osca-Verdegal R, Pallardó F. V. et al. Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches. Crit Care Med. 2020 Sep 1 .Published online 2020 Aug 21. doi: 10.1097/CCM.0000000000004625.
11. Sreenath Meegada, Vijayadershan Muppidi, Donald C Wilkinson, Suman Siddamreddy, and Shravan K Katta .Coronavirus Disease 2019-Induced Rhabdomyolysis. Cureus. 2020 Aug; 12(8): e10123.Published online 2020 Aug 29. doi: 10.7759/cureus.10123.
12. Prof Claudio Ronco, MD .Thiago Reis, MD.Faeq Husain-Syed, MD. Management of acute kidney injury in patients with COVID-19. VIEWPOINT| VOLUME 8, ISSUE 7, P738-742, JULY 01, 2020 Published:May 14, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30229-0
13. Johns Hopkins medicine. Coronavirus: Kidney Damage Caused by COVID-19 https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-kidney-damage-caused-by-covid19
14. Tarragón B, Valdenebro M, Serrano ML, Maroto A, Llópez-Carratalá MR, Ramos A, et al. Acute kidney failure in patients admitted due to COVID-19. Nefrología (English Edition). 2021;41(1):34-40. DOI:10.1016/j.nefroe.2020.08.005
15. Dhineshreddy Gurala,. Hassan Al Moussawi. Jobin Philipose, and Jeffrey R Abergel. Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease. Cureus. 2020 Aug; 12(8): e10045.Published online 2020 Aug 26. doi: 10.7759/cureus.10045.
16. Salvatore Pepe, Ann T. Gregory, MBBS, GradCertPopHealth, and A. Robert Denniss. Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination. Heart Lung Circ. 2021 Oct; 30(10): 1425–1429.
17. Ángela Irabien-Ortiza, José Carreras-Morab, Alessandro Sionisb, Julia Pàmiesb, José Montiela, Manel Taurona. Fulminant myocarditis due to COVID-19. Revista espanola de cardiologia Vol. 73. Issue 6. pages 503-504 (June 2020) DOI: 10.1016/j.rec.2020.04.005.
18. Ranard L. S., Fried J.A., Abdalla M., AnsteyD. E., Givens R. C., Kumaraiah D., Susheel K. et al. Approach to Acute Cardiovascular Complications in COVID-19Infection. Circ Heart Fail. 2020 Jul;13(7):e007220. doi: 10.1161/CIRCHEARTFAILURE.120.007220.
19. Massimo Imazio. COVID-19 as a Possible Cause of Myocarditis and Pericarditis. American college of cardiology. Feb 05, 2021. Expert Analysis.
20. Angelo Valerio Marzano, Nicoletta Cassano, Chiara Moltrasio, Lucio Verdonie Giovanni Genovese, Gino Antonio Vena. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings. Dermatology. 2021 Jun 1;1-9. doi: 10.1159/000515449.
21. Johns Hopkins medicine. MIS-C and COVID-19: Rare Inflammatory Syndrome in Kids and Teens https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/misc-and-covid19-rare-inflammatory-syndrome-in-kids-and-teens.
22. Mayo Clinic. Multisystem inflammatory syndrome in children (MIS-C) and COVID-19 https://www.mayoclinic.org/diseases-conditions/mis-c-in-kids-covid-19/symptoms-causes/syc-20502550
23. Julie G. Shulman, Thomas Ford, and Anna M. Cervantes-Arslanian,. Neurologic Emergencies during the Coronavirus Disease 2019 Pandemic. Neurol Clin. 2021 May; 39(2): 671–687.Published online 2021 Mar 26. doi: 10.1016/j.ncl.2021.02.007.
24. Vahid Reisi-Vanani, Zahra Lorigooini, Mohamad Ali Dayani, Mehrandokht Mardani & Fereidoun Rahmani. Massive intraperitoneal hemorrhage in patients with COVID-19: a case series. J Thromb Thrombolysis 2021 Apr 28 : 1–7. doi: 10.1007/s11239-021-02447-x.
25. Behzad Nematihonar, Shohra Qaderi, Jaffer Shah & Javad zebarjadi Bagherpour. Spontaneous giant rectus sheath hematoma in patients with COVID-19: two case reports and literature review. BMC International Journal of Emergency Medicine (2021) 14:40. https://doi.org/10.1186/s12245-021-00366-5.